THE CACO-2 CELL MONOLAYERS AS AN INTESTINAL METABOLISM MODEL - METABOLISM OF DIPEPTIDE PHE-PRO

被引:47
作者
HU, M
CHEN, J
TRAN, D
ZHU, Y
LEONARDO, G
机构
[1] Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Pullman, WA
关键词
PEPTIDE; INTRACELLULAR METABOLISM; CACO-2; TRANSCELLULAR TRANSPORT; INTESTINAL EPITHELIUM;
D O I
10.3109/10611869409015895
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolism of Phe-Pro was investigated in Caco-2 cell monolayers, a model of small intestinal epithelium. The results indicate that the majority of Phe-Pro was hydrolyzed during passage from the apical (AP) to basolateral (BL) side. The enzyme responsible for the hydrolysis is prolidase, a cytosolic enzyme. Through kinetic studies of a supematant enzyme preparation, a K(m) of 30.4 mu M and V(max) of 38.9 nmol/min per mg of protein were obtained. The enzyme catalyzed hydrolysis was inhibited by proline (66%), Zn++ (86%), Cu++ (100%), Fe+++ (100%), PCMB (89%), and captopril (66%), but not by leucine. We also studied the transcellular transport of Phe-Pro by measuring the amount of Phe in the receiver media. In the presence of a proton gradient (AP pH6, BL pH7.4), the appearance rate of Phe in the BL media after Phe-Pro was loaded apically was at least 100 times faster than that in the AP media after Phe-Pro was loaded basolaterally. The former is also higher than the appearance rate of Phe without a transepithelial proton gradient (pH 6-pH 6) or against a proton gradient (pH7.4-pH6). The rate of appearance of Phe in the BL media (pH7.4) after Phe-Pro was loaded on the AP side (pH 6) was decreased by the presence in the AP media of proline (42%), leucine (40%), and captopril (17%), but not by Zn++. In conclusion, the transmembrane uptake of Phe-Pro is dependent on a proton gradient, and the intracellular metabolism of Phe-Pro is complete via hydrolysis by prolidase.
引用
收藏
页码:79 / 89
页数:11
相关论文
共 37 条
[1]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[2]   UTILIZATION OF PEPTIDE CARRIER SYSTEM TO IMPROVE INTESTINAL-ABSORPTION - TARGETING PROLIDASE AS A PRODRUG-CONVERTING ENZYME [J].
BAI, JPF ;
HU, M ;
SUBRAMANIAN, P ;
MOSBERG, HI ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :113-116
[3]   CLONAL ANALYSIS OF SUCRASE ISOMALTASE EXPRESSION IN THE HUMAN COLON ADENOCARCINOMA CACO-2 CELLS [J].
BEAULIEU, JF ;
QUARONI, A .
BIOCHEMICAL JOURNAL, 1991, 280 :599-608
[4]   PHARMACOKINETIC PROPERTIES OF THE CEPHALOSPORINS [J].
BERGAN, T .
DRUGS, 1987, 34 :89-104
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
DANTZIG, AH ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) :211-217
[7]  
DARMOUL D, 1992, J BIOL CHEM, V267, P4824
[8]  
HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
[9]   A SURVEY OF MEMBRANE PEPTIDASES IN 2 HUMAN COLONIC CELL-LINES, CACO-2 AND HT-29 [J].
HOWELL, S ;
KENNY, AJ ;
TURNER, AJ .
BIOCHEMICAL JOURNAL, 1992, 284 :595-601
[10]   MECHANISM OF L-ALPHA-METHYLDOPA TRANSPORT THROUGH A MONOLAYER OF POLARIZED HUMAN INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
HU, M ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1990, 7 (12) :1313-1319